000148609 001__ 148609
000148609 005__ 20240229112706.0
000148609 037__ $$aDKFZ-2019-03157
000148609 082__ $$a610
000148609 1001_ $$0P:(DE-HGF)0$$aKloo$$b0
000148609 245__ $$aResitance of the stable - towards more recise prediction of Response to immune checkpoint Blockade in microsatellite-unstable Cancer patients
000148609 260__ $$aShatin, NT$$bAME Publishing Company$$c2019
000148609 3367_ $$2DRIVER$$aarticle
000148609 3367_ $$2DataCite$$aOutput Types/Journal article
000148609 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1580886108_4174$$xEditorial
000148609 3367_ $$2BibTeX$$aARTICLE
000148609 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000148609 3367_ $$00$$2EndNote$$aJournal Article
000148609 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000148609 773__ $$0PERI:(DE-600)2893931-1$$n1$$p5$$tAnnals of translational medicine$$v1$$x2305-5839$$y2019
000148609 909CO $$ooai:inrepo02.dkfz.de:148609$$pVDB
000148609 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000148609 9141_ $$y2019
000148609 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000148609 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000148609 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000148609 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000148609 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000148609 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000148609 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000148609 9201_ $$0I:(DE-He78)F210-20160331$$kF210$$lAngewandte Tumorbiologie$$x0
000148609 980__ $$ajournal
000148609 980__ $$aVDB
000148609 980__ $$aI:(DE-He78)F210-20160331
000148609 980__ $$aUNRESTRICTED